BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35839551)

  • 1. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
    Xavier-Junior JCC; Ocanha-Xavier JP
    Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dysplastic melanocytic nevus].
    Bierhoff E
    Pathologe; 2015 Feb; 36(1):46-50, 52. PubMed ID: 25591417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
    Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
    Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
    Cockerell CJ; Berson DS
    Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplastic nevi.
    Farber MJ; Heilman ER; Friedman RJ
    Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 and D3 expression in melanocytic skin lesions.
    Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
    Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
    Piepkorn M
    Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic classification of the combined nevus. Analysis of the variable expression of melanocytic nevi.
    Pulitzer DR; Martin PC; Cohen AP; Reed RJ
    Am J Surg Pathol; 1991 Dec; 15(12):1111-22. PubMed ID: 1746678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysplastic nevus part II: Dysplastic nevi: Molecular/genetic profiles and management.
    Spaccarelli N; Drozdowski R; Peters MS; Grant-Kels JM
    J Am Acad Dermatol; 2023 Jan; 88(1):13-20. PubMed ID: 36252690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation.
    Kelly JW; Crutcher WA; Sagebiel RW
    J Am Acad Dermatol; 1986 Jun; 14(6):1044-52. PubMed ID: 3722481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursors to melanoma and their mimics: nevi of special sites.
    Elder DE
    Mod Pathol; 2006 Feb; 19 Suppl 2():S4-20. PubMed ID: 16446715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histopathology of dysplastic nevi. Continued controversy.
    Roth ME; Grant-Kels JM; Ackerman AB; Elder DE; Friedman RJ; Heilman ER; Maize JC; Sagebiel RW
    Am J Dermatopathol; 1991 Feb; 13(1):38-51. PubMed ID: 2003647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.
    Albert LS; Rhodes AR; Sober AJ
    J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC; Barnhill RL
    Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.